Got Something To Say About CBD? The FDA Wants To Hear It

The Federal Food and Drug Administration (FDA) wants to know what you think about CBD.

The agency is currently seeking public input at Regulations.Gov on the therapeutic ability and abuse liability of several controlled substances, including CBD – formally known as cannabidiol.

Comments will be used to help inform the FDA ahead of its official response to the World Health Organization, which is considering placing certain substances within their international drug scheduling code.

Despite its non-psychoactive nature, CBD is classified as a Schedule I controlled substance by the U.S. Drug Enforcement Administration – alongside THC, LSD and heroin.

Seventeen states currently recognize CBD as a therapeutic substance, while the head of the U.S. National Institute on Drug Abuse has acknowledged that it is a “safe drug with no addictive effects.”

The FDA will accept comments on CBD until Sept. 13, 2017. More information on submitting your comments can be found here.  

h/t NORML Blog


Derived from the part of the cannabis plant that doesn't get you “high” like THC, cannabidiol (CBD) is typically used for health reasons instead of for recreational purposes, and has been found to be especially useful for treating symptoms of Parkinson’s disease. A challenging neurodegenerative disorder, Parkinson’s causes a combination of motor and non-motor symptoms — such as tremors, weakness, stiffness, dizziness, anxiety and sleeplessness — that affect daily life. CBD, typically taken in oil form, has the potential to relieve these symptoms, improving sleep, reducing inflammation and more, which can profoundly help the more than 10 million people across the world suffering.

Can we see some ID please?

You must be 19 years of age or older to enter.